ClinicalTrials.gov
ClinicalTrials.gov Menu

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003494
Recruitment Status : Terminated (Slow accrual)
First Posted : January 27, 2003
Last Update Posted : January 31, 2018
Sponsor:
Information provided by (Responsible Party):
Burzynski Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : May 26, 2002
  Actual Study Completion Date : May 26, 2002